Research teams in the UK and the US have also been investigating nasal spray vaccines. In November, India's drug regulator approved the use of iNCOVACC as a heterologous booster dose - a booster ...
In India too, ITC was reported developing a nasal spray to prevent infection and transmission of COVID-19. The nasal spray is designed to stop the virus at the entry point in the nasal cavity itself.